“…iTreg can be characterized as CD4+CD25 hi cells that proliferate in response to specific antigens (i.e., CFSE lo or CD40L/CD69+) 32–35 . iTreg can be Foxp3+ and/or TGF-β+ and/or IL-10+ 32,34,36,37,49,68 . Type 1 regulatory T cells (Tr1) release IL-10 28,38,39 and express CD4, CD49, and LAG3 on their surface 28,38,39 which differs from nTreg expressing CD4, CD25 hi , CD127 lo , and perhaps by Helios on their surface 25–27,40–43 .…”